TRICYCLIC P13K INHIBITOR COMPOUNDS AND METHODS OF USE

Formula I compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. The dashed lines indicate an optional double bond, and at least one dashed line is a double bond. The substituents are as described.

Saved in:
Bibliographic Details
Main Authors Heald, Robert Andrew, Jones, Graham Elgin, McLean, Neville James, Dotson, Jennafer, Heffron, Timothy, Salphati, Laurent, Wei, BinQing, Ndubaku, Chudi, Olivero, Alan G, Wang, Lan, Krintel, Sussie Lerche
Format Patent
LanguageEnglish
Published 31.10.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Formula I compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. The dashed lines indicate an optional double bond, and at least one dashed line is a double bond. The substituents are as described.
Bibliography:Application Number: US201916507523